Medicis
Executive Summary
Introducing Dynacin (minocycline), a branded generic version of Lederle's Minocin antibiotic, in November. Dynacin will be manufactured by Schein Pharmaceutical and marketed by Medicis at an approximate 40% discount to Lederle's innovator product; the average wholesale price for Lederle's Minocin 50 mg is $136.66 for 100 capsules, according to the October Red Book. Warner- Chilcott has been marketing generic minocycline since August 1990; Medicis estimates the current market for minocycline, the top- selling Rx oral antibiotic acne treatment, is over $150 mil.
You may also be interested in...
Part D Discount Liability Coming Into Focus: CMS Releases Drug Cost Data
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011
FDA Skin Infections Guidance Spurs Debate On Endpoint Relevance
FDA appears headed for a showdown with clinicians and the pharmaceutical industry over the proposed new clinical trial endpoints for acute bacterial skin and skin structure infections, the guidance's approach for justifying a non-inferiority margin and proposed changes in the types of patients that should be enrolled in trials
Shire Hopes To Sow Future Deals With $50M Venture Fund
Specialty drug maker Shire has quietly begun scouting deals with a brand-new $50 million venture fund, the latest of several in-house investment arms to launch with their parent company's pipelines, not profits, as the measure of their worth